Influence of Urinary Tract Instrumentation and Inflammation on the Performance of Urine Markers for the Detection of Bladder CancerTODENHOFER, Tilman; HENNENLOTTER, Jörg; KÜHS, Ursula et al.Urology (Ridgewood, NJ). 2012, Vol 79, Num 3, pp 620-624, issn 0090-4295, 5 p.Article

Preliminary Experience on the Use of the Adnatest^® System for Detection of Circulating Tumor Cells in Prostate Cancer PatientsTODENHÖFER, Tilman; HENNENLOTTER, Jorg; STENZL, Arnulf et al.Anticancer research. 2012, Vol 32, Num 8, pp 3507-3513, issn 0250-7005, 7 p.Article

Individual risk assessment in bladder cancer patients based on a multi-marker panelTODENHÖFER, Tilman; HENNENLOTTER, Jörg; AUFDERKLAMM, Stefan et al.Journal of cancer research and clinical oncology. 2013, Vol 139, Num 1, pp 49-56, issn 0171-5216, 8 p.Article

Serum receptor activator of nuclear factor κB ligand (RANKL) levels predict biochemical recurrence in patients undergoing radical prostatectomyTODENHÖFER, Tilman; HENNENLOTTER, Jörg; STENZL, Arnulf et al.BJU international (Papier). 2014, Vol 113, Num 1, pp 152-159, issn 1464-4096, 8 p.Article

Activation of the PKB/Akt pathway in histological benign prostatic tissue adjacent to the primary malignant lesionsMERSEBURGER, Axel S; HENNENLOTTER, Jörg; SIMON, Perikles et al.Oncology reports. 2006, Vol 16, Num 1, pp 79-83, issn 1021-335X, 5 p.Article